..................................................................................................................................................................................
EDITORIAL
Lipid lowering in chronic kidney disease: What did we
learn from the 4D study?
Vera Krane, Christoph Wanner
Rev Port Nefrol Hipert 2006; 20 (2): 77-80
REVIEW ARTICLE
The adipose tissue as a source of vasoactive hormones and
cytokines with a potential role in the pathogenesis of
cardiovascular and renal diseases.
Jerzy Chudek, Marcin Adamczak, Teresa Nieszporek, Andrzej Więcek
Rev Port Nefrol Hipert 2006; 20 (2): 81-91
ORIGINAL ARTICLES
High-flux haemodialysis with polysulfone dialysers
reduces peripheral blood lymphocyte apoptosis.
Helena Sá, Vera Alves, Filomena Oliveira, Anabela Mota Pinto,
Mário Campos, Manuel Santos Rosa
Rev Port Nefrol Hipert 2006; 20 (2): 93-110
Individualización de las soluciones de bicarbonato sódico
durante la hemodiálisis.
Manuel Heras, Rosa Sánchez, Maria J. Fernández Reyes, Carmen Mon,
Mercedes Gonzalez, Alvaro Molina, Fernando Alvarez Ude
Rev Port Nefrol Hipert 2006; 20 (2): 111-116
Terapêutica endovascular de estenoses venosas centrais:
uma avaliação prospectiva.
Carlos Lucas, Célia Gil, António Martinho, Maria João Pais
Rev Port Nefrol Hipert 2006; 20 (2): 117-123
CASE REPORTS
Nefropatia Isquémica.
Carmen do Carmo, Sérgio Lemos, Luis Freitas, Henrique Gomes,
Mário Campos
Rev Port Nefrol Hipert 2006; 20 (2): 125-130
Triple regimen with Rituximab, Plasmapheresis and
intravenous Immunoglobulin in the treatment of dialysis
dependent acute humoral-mediated rejection in kidney grafts.
Pedro Pessegueiro, Fernando Nolasco, Sandra Sampaio, Fernanda
Carvalho, Felicidade Manuel, Engrácia Barber, Helena Viana, João
Sousa, Marília Possante, Margarida Domingos, José Reimão Pinto,
João Ribeiro Santos, Eduardo Barroso
Rev Port Nefrol Hipert 2006; 20 (2): 131-135
|
